Drug Screening Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019-2024

2019 Research Report on Global Drug Screening Market is a professional and comprehensive report on the Drug Screening industry.

#Download Free PDF Sample Brochure of report Global Drug Screening Market 2019 across with 203 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=345782

Key Players: Alere (US), Thermo Fisher (US), Dr?gerwerk (Germany), LabCorp (US), Quest Diagnostics (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), OraSure (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), Seimens Healthineers (US).

"Global drug screening market projected to grow at a CAGR of 10.2% during the forecast period"

The drug screening market is expected to reach USD 8.63 billion by 2022 from USD 5.32 billion in 2017, at a CAGR of 10.2%. Growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the presence of government funding in major markets are factors driving the growth of the drug screening market. On the other hand, market growth may be limited to a certain extent due to the prohibition of workplace drug testing in some countries and the ban on alcohol consumption in several Islamic countries.

"Drug screening services are expected to grow at the highest CAGR during the forecast period"

Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period; growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.

"By sample type, urine samples are expected to dominate the market during the forecast period"

The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

"Asia Pacific to witness high growth during the forecast period"

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

Place a Direct Purchase Order and Get Flat 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=345782

In the end, the Global Drug Screening Market report's conclusion part notes the estimation of the industry veterans.

Connect Us for more information at sales@reportsandreports.com or Call Us + 1 888 391 5441.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.